ProJenX teamed with Unlearn to create digital twins of ALS patients as a placebo group in open-label extension of Phase 1 ...

The addition of the cancer immunotherapy drug atezolizumab to the standard of care concurrent chemoradiation (cCRT) did not ...

Clinical trial recruitment stands at the forefront of drug and medical device development for companies, yet it often encounters significant hurdles.

The trial's primary goal is to assess the efficacy, safety and tolerability of daily oral doses of SCI-110 in adults aged 18 ...

After a six-month beta testing period, the European Clinical Trials Information Network is rolling out its patient ...

FDA confirms that SciSparc’s study may proceedonly a month after application submission TEL AVIV, Israel, Sept. 30, 2024 (GLOBE NEWSWIRE) -- ...

Mural Oncology a clinical-stage oncology company focused on discovering and developing immunotherapies, held its first ...

In September 2024, the U.S. Food and Drug Administration (FDA) issued three guidance documents to support different clinical ...

Maze Therapeutics, a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with common diseases, ...

Results of the human clinical trial will be shared with LifeVantage Consultants at Market Connect in Kansas City, October ...

Pioneering Study in Parkinson's Disease to Advance Surgical Treatment Options RebrAIn, a leader in precise targeting solutions for deep brain stimulation (DBS) and lesion techniques, today announced ...

Avera participates in numerous clinical trials, including ones that are Phase 1. In this Avera Medical Minute, we share what ...